Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
- · 29d
- Not stated
- 5
- Apr 29, 2026
Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.
Summary
Rapid-acting psychotropic interventional drugs (RAPIDs) are a class of psychoactive drugs that produce intense subjective effects and include 5-HT2A agonists such as psilocybin and lysergic acid diethylamide (LSD), dissociative anesthetics such as ketamine, and entactogens such as 3,4-methylenedioxymethamphetamine (MDMA). […]
Other topics in this solicitation
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- All 3 review criteria reviewers score this against, extracted from this announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k